SITC Cancer Immunotherapy Month™ Events The Society for Immunotherapy of Cancer (SITC) celebrates Cancer Immunotherapy Month™ every June, promoting not only general awareness of the field of cancer immunotherapy, but also providing educational growth and professional development opportunities...
The SITC fellowship award program was established through the Forward Fund to support the development of young investigators in cancer immunotherapy research to cultivate the next generation of cancer immunotherapy experts. 2024 SITC Fellowship opportunities closed April 1. 2024 SITC...
Future Annual Meetings The following are future scheduled dates and locations for the society's Annual Meeting & Pre-Conference Programs: SITC 2025 Wednesday, Nov. 5–Sunday, Nov. 9, 2025 Gaylord National Resort and Convention Center National Harbor, Md. SITC 2026 Wednesday, Nov. 4–Sunday...
Guideline News CPG Mobile App The SITC Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, offering direct, easy, portable access to SITC’s CPGs via phone or tablet. Highlighting key information from SITC’s published guidelines, the SITC CPG Mobile App...
The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with advanced renal cell carcinoma (aRCC). Nivolumab, a programmed death 1 (PD-1) immune checkpoint inhibitor monoclonal antibody, was approved as...
Continuing Education Credit Information for Clinical Updates from Immuno-Oncology Congress 2019 Webinar Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here . Joint Accreditation Statement In support of...
A Message from the President Dear Colleagues, I would like to begin my final President's Message of 2019 by expressing our sincere appreciation to the 4,800 cancer immunotherapy professionals who attended our society's 34th Annual Meeting & Pre-Conference Programs (SITC 2019) in National...
Immunotherapy was approved in 2015 to treat advanced lung cancer. It is very different from other types of cancer treatment because it uses the body's own immune system to recognize and attack cancer cells that have been hiding and targets them for destruction. Immunotherapy is a systemic...
2019 Immunotherapy Lung.pdf
Learning you have head and neck cancer can fell overwhelming. Give yourself time to digest the news, and then focus on learning as much as you can about your exact diagnosis. Knowing ket information will better prepare you to make well-informed decisions with your doctor. This guide, published...
2019 Immunotherapy H&N.pdf
Immunotherapy is one of the latest types of treatment that is being used to treat cancer by stimulating one's immune system to prevent, control, and eliminate cancer. This video from AIM at Melanoma explains how your immune system works, how immunotherapy treatments works, as well as possible...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us